Nos publications

Les équipes du CRCM publient chaque année plus de 130 articles de recherche fondamentale, translationnelle et clinique.

Photo de profil par défault
Feb 2020 Molecular biology of the cell

Aurora B and Condensin are dispensable for chromosome arm and telomere separation during meiosis II.

Berthezene J, Reyes C, Li T, Coulon S, Bernard P, Gachet Y, Tournier S

Feb 2020 Forensic science international. Genetics

Paternal and maternal mutations in X-STRs: A GHEP-ISFG collaborative study.

Pinto N, Pereira V, Tomas C, Loiola S, Carvalho EF, Modesti N, Maxzud M, Marcucci V, Cano H, Cicarelli R, Januario B, Bento A, Brito P, Burgos G, Paz-Cruz E, Díez-Juárez L, Vannelli S, Pontes ML, Berardi G, Furfuro S, Fernandez A, Sumita D, Bobillo C, García MG, Gusmão L

Photo de profil par défault
Feb 2020 Journal of molecular biology

Telomeric Transcription and Telomere Rearrangements in Quiescent Cells.

Coulon S, Vaurs M

Photo de profil par défault
Feb 2020 Breast cancer research and treatment

Inflammatory breast cancer cells are characterized by abrogated TGFβ1-dependent cell motility and SMAD3 activity.

Rypens C, Marsan M, Van Berckelaer C, Billiet C, Melis K, Lopez SP, van Dam P, Devi GR, Finetti P, Ueno NT, Bertucci F, Dirix P, Neven P, Vermeulen P, Dirix L, Van Laere SJ

Photo de profil par défault
Feb 2020 Blood

EBV+ diffuse large B-cell lymphoma associated with chronic inflammation expands the spectrum of breast implant-related lymphomas.

Mescam L, Camus V, Schiano JM, Adélaïde J, Picquenot JM, Guille A, Bannier M, Ruminy P, Viailly PJ, Jardin F, Bouabdallah R, Brenot Rossi I, Bohers E, Robe C, Laurent C, Birnbaum D, Wotherspoon A, Gaulard P, Xerri L

Photo de profil par défault
Feb 2020 European journal of cancer (Oxford, England : 1990)

A double-blind placebo-controlled randomized phase II trial assessing the activity and safety of regorafenib in non-adipocytic sarcoma patients previously treated with both chemotherapy and pazopanib.

Penel N, Mir O, Wallet J, Ray-Coquard I, Le Cesne A, Italiano A, Salas S, Delcambre C, Bompas E, Bertucci F, Saada-Bouzid E, Chaigneau L, Chevreau C, Brodowicz T, Decoupigny E, Vanseymortier M, Laroche L, Taieb S, Le Deley MC, Blay JY

Photo de profil par défault
Feb 2020 Cancer research

Correction: CD95L Cell Surface Cleavage Triggers a Prometastatic Signaling Pathway in Triple-Negative Breast Cancer.

Malleter M, Tauzin S, Bessede A, Castellano R, Goubard A, Godey F, Levêque J, Jézéquel P, Campion L, Campone M, Ducret T, MacGrogan G, Debure L, Collette Y, Vacher P, Legembre P

Photo de profil par défault
Feb 2020 Expert opinion on biological therapy

Role of Inducible Co-Stimulator (ICOS) in cancer immunotherapy.

Amatore F, Gorvel L, Olive D

Photo de profil par défault
Feb 2020 Bulletin du cancer

Lambert S, Borde V, Charbonnier JB, Dantzer F, Espéli O, Guirouilh-Barbat J, Llorente B, Legube G, Prioleau MN, Radicella P

Photo de profil par défault
Feb 2020 eLife

Human RPA activates BLM’s bidirectional DNA unwinding from a nick.

Qin Z, Bi L, Hou XM, Zhang S, Zhang X, Lu Y, Li M, Modesti M, Xi XG, Sun B